LARIMAR THERAPEUTICS, INC. (LRMR) Return on equity 2016–2018
LARIMAR THERAPEUTICS, INC. (LRMR) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-2106.0%FY2018 · since FY2016: -47.5% → -2106.0%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | -2106.0% | -2039.5 pp |
| FY2017 | -66.5% | -19.0 pp |
| FY2016 | -47.5% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More LRMR financial trends
LRMR RevenueLRMR Net incomeLRMR Net marginLRMR Gross profitLRMR Gross marginLRMR Operating incomeLRMR Operating marginLRMR Operating cash flowLRMR Free cash flowLRMR Capital expendituresLRMR Stock buybacksLRMR Dividends paidLRMR Total assetsLRMR Total liabilitiesLRMR Shareholders’ equityLRMR overview →